TrialDiabetes, obesity & metabolism2011

Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.

M-R Taskinen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.